Search

Search Constraints

You searched for: Author/Creator Hattori, Nobuhiro

Search Results

1. Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis. Issue 2 (5th January 2021)

2. Comparative study between sorafenib and lenvatinib as the first‐line therapy in the sequential treatment of unresectable hepatocellular carcinoma in a real‐world setting. Issue 1 (17th December 2021)

3. Daclatasvir and asunaprevir improves health‐related quality of life in Japanese patients infected with hepatitis C virus. Issue 3 (14th May 2018)

4. Fusobacterium nucleatum detected simultaneously in a pyogenic liver abscess and advanced sigmoid colon cancer. (December 2017)

5. Impact of resistance‐associated variant dominancy on treatment in patients with HCV genotype 1b receiving daclatasvir/asunaprevir. Issue 1 (6th July 2016)

6. Naturally occurring, resistance‐associated hepatitis C virus NS5A variants are linked to interleukin‐28B genotype and are sensitive to interferon‐based therapy. Issue 10 (October 2015)

7. Prediction of esophagogastric varices associated with oxaliplatin administration. Issue 11 (2nd November 2021)

8. Risk factors for liver‐related mortality of patients with hepatitis C virus after sustained virologic response to direct‐acting antiviral agents. Issue 10 (26th August 2022)

9. Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis. Issue 3 (30th November 2021)

10. Wisteria floribunda agglutinin positive human Mac‐2‐binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients. Issue 10 (28th January 2015)